2NN & CHARM Long-Term Follow-up Study

PHASE4CompletedINTERVENTIONAL
Enrollment

763

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

April 30, 2007

Conditions
HIV Infections
Interventions
DRUG

stavudine

DRUG

lamivudine

DRUG

nevirapine

DRUG

efavirenz

DRUG

trizivir

Trial Locations (1)

NSW2010

Holdsworth House Medical Practice, Darlinghurst

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

International Antiviral Therapy Evaluation Center

OTHER